Dr. Jacobs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
120 E 56th St
Rm 1040
New York, NY 10022Phone+1 212-888-0002Fax+1 212-888-1899
Education & Training
- Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1995
- Mount Sinai Beth Israel HospitalFellowship, Behavioral neurology, 1993 - 1994
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1990 - 1993
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1989 - 1990
- Duke University School of MedicineClass of 1989
- Duke UniversityB.A, Cum Laude, 2012 - 1984
Certifications & Licensure
- NY State Medical License 1990 - 2026
- FL State Medical License 2021 - 2023
- TX State Medical License 2022 - 2022
- CT State Medical License 2006 - 2010
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Magna Cum Laude Duke University, 1984
- Phi Eta Zeta, Freshman Honor Society Duke University, 1980
Publications & Presentations
PubMed
- 21 citationsSustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MS.Jens Kuhle, Nadia Daizadeh, Pascal Benkert, Aleksandra Maceski, Christian Barro
Multiple Sclerosis. 2021-08-11 - 33 citationsEfficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial:Alasdair Coles, Douglas L. Arnold, Ann D Bass, Aaron Boster, D Alastair S Compston
Therapeutic Advances in Neurological Disorders. 2021-04-23 - 19 citationsEfficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, an...Giancarlo Comi, Raed Alroughani, Aaron Boster, Ann D Bass, Regina Berkovich
Multiple Sclerosis. 2020-12-01
Journal Articles
- Source and function of keto elaidic acids for lungs of cotton workers.Lynn WS, Lynn D, Sachs C, Phillips N, Jacobs A, Arch Environ Health
- Psychiatric classification of nonconversion nonepileptic seizures[Letter].Jacobs AR, Herzog AG, Arch Neurol
- Apolipoprotein E4 is associated with chronic traumatic brain injury in boxing.Jordan B, Relkin N, Ravdin L, Jacobs A, JAMA
- Join now to see all
Abstracts/Posters
- Cholinergic innervation of the lateral geniculate nucleus: Projections to other thalamic and midbrain structures in tree shrew.Jacobs A, Fitzpatrick D, Raczkowski D, Diamond IT, Society for Neurosciences, e.g. San Mateo
- Hormonally responsive anxiety and maladaptive behavioral disorders in men and women with congenital adrenal hyperplasia.Jacobs AR, Coleman AE, Herzog AG, J Neuropsych and Clin Neurosciences, e.g. San Mateo
- Congenital adrenal hyperplasia: Presentation as nonepileptic seizures.Herzog AG, Jacobs AR, American Epilepsy Society, e.g. San Mateo
- Join now to see all
Lectures
- Department of Medicine Grand Rounds .Woodhull Hospital Center, Brooklyn, NY
- Department of Geriatrics Clinical Rounds.St. Vincent’s Hospital, New York, NY
- The Nature of Dementia in Parkinson’s disease.Ridgefield Crossing. Ridgefield, CT
- Join now to see all
Research History
- A Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of Simvastatin to Slow the Progression of Alzheimer’s disease.Alzheimer’s Disease Cooperative Study. PI, Mary Sano, PhD2002 - Present
- The Effects of Hormone Replacement on Menopausal Women with Epilepsy.NIH Co-investigator. PI, Cynthia L. Harden, MD2000 - 2003
- Alzheimer’s Disease Prevention Trial with Estrogens.NIH, NIA Co-investigator. PI, Mary Sano, PhD1999 - 2002
Other Languages
- Spanish
External Links
- my websitehttp://www.neuroendocrinology.org
- my Bloghttp://www.blog.alanjacobsmd.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: